Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06047405 · ClinicalTrials.gov registry record · NA
NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP
A NA study of Hypercapnic Respiratory Failure, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06047405 is a NA study of Hypercapnic Respiratory Failure that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06047405, a NA study of Hypercapnic Respiratory Failure, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare two different modes of noninvasive ventilation in hypercapnic respiratory failure. The investigators will compare AVAPS and BIPAP S/T and hypothesize that AVAPS will result in a decreased length of stay in the ICU or on telemetry. Currently, noninvasive ventilation is the standard of care for hypercapnic respiratory failure. However, the most effective mode for patients with hypercapnic respiratory failure is unclear.
Conditions Studied
Interventions
- DEVICE Average Volume-Assured Pressure Support (AVAPS)
- DEVICE Bilevel Positive Airway Pressure Spontaneous Timed (BIPAP S/T)
Study Locations (1)
New York
- Lenox Hill Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-07 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06047405
The ClinicalTrials.gov registry entry for NCT06047405 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypercapnic Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Average Volume-Assured Pressure Support (AVAPS) is the first listed.
NCT06047405 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06047405 about?
NCT06047405 is a clinical study titled "NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP". The goal of this study is to compare two different modes of noninvasive ventilation in hypercapnic respiratory failure. The investigators will compare AVAPS and BIPAP S/T and hypothesize that AVAPS will result in a decreased length of stay in the ICU or on telemetry. Currently, noninvasive ventilati...
What is the current status of trial NCT06047405?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-07. Estimated completion is 2026-09-01.
What conditions does trial NCT06047405 study?
This clinical trial studies the following conditions: Hypercapnic Respiratory Failure.
What interventions are being tested in trial NCT06047405?
The interventions under investigation include: Average Volume-Assured Pressure Support (AVAPS) (DEVICE), Bilevel Positive Airway Pressure Spontaneous Timed (BIPAP S/T) (DEVICE).
Who is sponsoring clinical trial NCT06047405?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06047405 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.